We are live on ! Find out more
TMBR

Timber Pharmaceuticals, Inc.
TMBR

Delisted

TMBR was delisted on the 28th of November, 2023.

Back to rankings

13 hedge funds and large institutions have $3.94M invested in Timber Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

18% more funds holding

Funds holding: 11 → 13 (+2)

8% less capital invested

Capital invested by funds: $4.3M → $3.94M (-$351K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$348K
2
AFM
Anson Funds Management
Texas
+$148K
3
PAM
Panagora Asset Management
Massachusetts
+$52.7K
4
NC
Nexthera Capital
New York
+$42.2K
5
FWSM
First Wilshire Securities Management
California
+$21.1K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$211K
2
TCM
Tenor Capital Management
New York
-$21.1K
3
Citadel Advisors
Citadel Advisors
Florida
-$9K
4
TSS
Two Sigma Securities
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$2.84M +$348K +33 +11%
RI
2
RTW Investments
New York
$389K – – –
SM
3
Sabby Management
Florida
$363K -$211K -20 -31%
AFM
4
Anson Funds Management
Texas
$114K +$148K +14 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$87K – – –
PAM
6
Panagora Asset Management
Massachusetts
$45K +$52.7K +5 New
NC
7
Nexthera Capital
New York
$32K +$42.2K +4 New
LPL Financial
8
LPL Financial
California
$18K – – –
VKH
9
Virtu KCG Holdings
New York
$17K – – –
FWSM
10
First Wilshire Securities Management
California
$16K +$21.1K +2 New
TCM
11
Tenor Capital Management
New York
$7K -$21.1K -2 -67%
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$6K – – –
UBS Group
13
UBS Group
Switzerland
$4K – – –
Bank of America
14
Bank of America
North Carolina
$2K – – –
BFA
15
BlackRock Fund Advisors
California
$1K – – –
Citadel Advisors
16
Citadel Advisors
Florida
– -$9K -1 Closed
TSS
17
Two Sigma Securities
New York
– -$9K -1 Closed

TMBR Hedge Fund Activity: Q3 2016 in Review

13 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q3 2016, worth a combined $3.94M — down 8.2% from $4.3M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TMBR positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Franklin Resources, adding an estimated $348K. The largest seller was Sabby Management, cutting an estimated $211K.

  • 13 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q3 2016, up from 11 in Q2 2016.
  • Funds reported $3.94M of Timber Pharmaceuticals, Inc. stock for Q3 2016, down 8.2% quarter-over-quarter.
  • 4 funds opened new Timber Pharmaceuticals, Inc. positions in Q3 2016 and 2 closed out, a net change of +2 holders.
  • The largest Timber Pharmaceuticals, Inc. buyer in Q3 2016 was Franklin Resources, an estimated $348K added.
  • The largest Timber Pharmaceuticals, Inc. seller in Q3 2016 was Sabby Management, an estimated $211K sold.

Based on aggregated 13F filings for Q3 2016.